Attached files

file filename
EX-32.2 - HARROW HEALTH, INC.ex32-2.htm
EX-31.2 - HARROW HEALTH, INC.ex31-2.htm
EX-31.1 - HARROW HEALTH, INC.ex31-1.htm
EX-23.1 - HARROW HEALTH, INC.ex23-1.htm
EX-21.1 - HARROW HEALTH, INC.ex21-1.htm
EX-10.60 - HARROW HEALTH, INC.ex10-60.htm
EX-10.58 - HARROW HEALTH, INC.ex10-58.htm
EX-10.57 - HARROW HEALTH, INC.ex10-57.htm
EX-4.1 - HARROW HEALTH, INC.ex4-1.htm
10-K - HARROW HEALTH, INC.form10-k.htm

 

Exhibit 32.1

 

HARROW HEALTH, INC.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Mark L. Baum, Chief Executive Officer of Harrow Health Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) the Annual Report on Form 10-K of the Company for the annual period ended December 31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 8, 2021  
   
/s/ Mark L. Baum  
Mark L. Baum  
Chief Executive Officer  

 

The foregoing certification is being furnished as an exhibit to the Report pursuant to Item 601(b)(32) of Regulation S-K and Section 1350 of Title 18 of the United States Code and, accordingly, is not being filed with the U.S. Securities and Exchange Commission as part of the Report and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Report, irrespective of any general incorporation language contained in such filing).